drugset / Trial / NCT00539136

A Study to Examine the Absorption of GSK561679 in Healthy Male Volunteers

NCT00539136

Phase 1 Completed 12 enrolled GlaxoSmithKline
Non-randomizedCrossoverOpen-labelDiagnostic

Summary

This study will be conducted in healthy volunteers to investigate the absorption of GSK561679 using Gamma Scintigraphy, PillCam™ SB capsule and the acoustic vest.

Timeline

Start
2007-10
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject VERUCERFONT Small molecule

Indications

No indication recorded.